In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Abstract The QDOT MICRO™ Catheter is a novel open‐irrigated contact force‐sensing
radiofrequency ablation catheter. It offers very high‐power short‐duration (vHPSD) ablation …

Background Pulmonary vein isolation (PVI) alone is insufficient to treat many patients with
persistent atrial fibrillation (PersAF). Adjunctive left atrial posterior wall (LAPW) ablation with …

Aims In-hospital complications of catheter ablation for atrial fibrillation (AF), atrial flutter
(AFL), and ventricular tachycardia (VT) may be overestimated by analyses of administrative …

Aims Recent trial data demonstrate beneficial effects of active rhythm management in
patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is …

Introduction Esophageal injury is one of the most serious complications of pulmonary vein
isolation (PVI) with thermic energy sources. Better tissue selectivity of primarily non‐thermic …

Introduction The major limitation of the current cryoballoon (CB) system is a fixed 28 mm
balloon‐size. We sought to analyze real‐world early experience with novel‐sized adjustable …

Pre‐organizing molecular drug within a microenvironment is crucial for the development of
efficient and controllable therapeutic systems. Here, we report the use of tetrahedral DNA …

Introduction Limited data exist on pulsed‐field ablation (PFA) in patients with persistent atrial
fibrillation (PeAF) undergoing left atrial posterior wall isolation (LAPWI). Methods The …

Objectives Pulsed field ablation (PFA) is a promising new ablation modality for the treatment
of atrial fibrillation (AF) that has recently become available in the UK National Health Service …